Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes.
10.4093/dmj.2015.39.4.316
- Author:
Hee Sook KIM
1
;
Hye Jung JANG
;
Jeong Eun PARK
;
Moon Young KIM
;
Sun Young KO
;
Sung Hoon KIM
Author Information
1. Department of Nursing, Dongnam Health University, Suwon, Korea.
- Publication Type:Original Article
- Keywords:
Pregnancy outcome;
Type 1 diabetes;
Type 2 diabetes
- MeSH:
Birth Weight;
Delivery of Health Care;
Female;
Gestational Age;
Hemoglobin A, Glycosylated;
Hospitals, General;
Humans;
Infant, Newborn;
Intensive Care, Neonatal;
Korea;
Pre-Eclampsia;
Pregnancy;
Pregnancy Outcome;
Retrospective Studies
- From:Diabetes & Metabolism Journal
2015;39(4):316-320
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The purpose of this study was to evaluate maternal and neonatal outcomes in Korean women with type 1 diabetes and type 2 diabetes. METHODS: We performed a retrospective survey of 163 pregnancies in women with type 1 diabetes (n=13) and type 2 diabetes (n=150) treated from 2003 to 2010 at Cheil General Hospital & Women's Healthcare Center, Korea. We compared maternal characteristics as well as maternal and neonatal outcomes between groups. RESULTS: Differences in glycosylated hemoglobin between type 1 and type 2 diabetes were not significant. Birth weight (3,501+/-689.6 g vs. 3,366+/-531.4 g) and rate of major congenital malformations (7.7% vs. 5.6%) were not significantly different. However, women with type 1 diabetes had higher rates of preeclampsia (38.5% vs. 8.2%, P=0.006), large for gestational age (LGA; 46.2% vs. 20.4%, P=0.004), macrosomia (38.5% vs. 13.4%, P=0.032), and admission for neonatal care (41.7% vs. 14.8%, P=0.03) than women with type 2 diabetes. CONCLUSION: Maternal and neonatal outcomes for women with type 1 diabetes were poorer than for women with type 2 diabetes, especially preeclampsia, LGA, macrosomia and admission to the neonatal intensive care unit.
